Lu Han

Critic
DISC Type : C

Co-founder & CEO at Imviva Biotech

New York, New York, United States

Overview

Lu Han is the Co-founder and CEO of Imviva Biotech, a clinical-stage company pioneering allogeneic CAR-T cell therapies. With a background in private equity from Morgan Stanley and an MSc from LSE, he now leads the development of "off-the-shelf" treatments for autoimmune diseases and cancer, backed by top investors.

Outside of his executive role, Lu demonstrates a personal commitment to advancing medical research. He has participated in fundraising events like the ASH Foundations morning run, showing his support for progress in blood disease research, a field directly related to his companys work.

His company, formerly Bioheng Therapeutics, rebranded to Imviva Biotech to reflect its strategic global expansion.

Personality Overview

ROI Driven

Precise

Objective Thinker

They don’t appreciate bells and whistles unless backed by data.  They prefer to analyze logically and value objective facts over emotions. They like to take decisions independently and do not seek others' support often.

Topics They Care About

Allogeneic CAR-T
Leads Imviva Biotech in developing "off-the-shelf" CAR-T cell therapies, with over 300 patients enrolled in programs for oncology and autoimmune diseases.
Autoimmune Therapies
His company's work was recently featured by the American College of Rheumatology, highlighting the potential of CAR-T to create an "immune-reset" for patients with diseases like lupus.
Biotech Investment
Leverages his past experience in private equity at Morgan Stanley and investment banking at HSBC to secure backing from leading investors like Hillhouse and Qiming.

Media Appearances

Lu has no verified media appearances

Work History

3-2018
Co-founder & CEO at Imviva Biotech
2013 - 2014
PE Investment at Morgan Stanley
2011 - 2012
Investment banking at HSBC
2009 - 2009
Equity Research Intern at SYWG BNP Paribas Asset Management
2008 - 2009
Internal Auditor Trainee at Lonza

Education

2010 - 2011
MSc from The London School of Economics and Political Science (LSE)
2005 - 2009
Bachelor from Sun Yat-sen University

More Information

Social Presence :

Prographics :

Exp : 13 Location : New York, New York, United States Job Level : Leadership Designation : Co-founder & CEO at Imviva Biotech
URL has been copied!

Insights For Selling To Lu

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Do not use very emotional or colorful language
  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Make extra effort to not seem pushy or confrontational

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Lu is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Lu

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Lu move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Lu take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Lu

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.